▼ SELL
$ Value
$202K
Shares
36,599
Price
$6
Filed
Aug 19
Insider
Name
Khan Najat
Title
Chief R&D Commercial Officer
CIK
0002020969
Roles
Director
Officer
Transaction Details
Transaction Date
2025-08-18
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
668,197
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. | Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units.
Filing Info
Khan Najat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-09 | RXRX | ▼ | $95K |
| 2026-02-17 | RXRX | F | $50K |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | A | $0 |
| 2026-02-06 | RXRX | F | $41K |
| 2025-12-22 | RXRX | ▼ | $549K |
| 2025-11-17 | RXRX | F | $73K |
| 2025-11-05 | RXRX | A | $0 |
| 2025-11-05 | RXRX | A | $0 |
| 2025-08-18 | RXRX | ▼ | $202K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | $68K | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $1.6M | 2026-04-07 |
| Gibson Christopher | — | $557K | 2026-04-07 |
|
Hallett David
Chief Scientific Officer
|
— | — | 2026-02-17 |
|
Khan Najat
CEO and President
|
— | $95K | 2026-03-09 |